![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, July 16, 2014 7:26:44 PM
As you know, NanoViricides, Inc (www.nanoviricides.com) has built Connecticut's first and only nanomedicines' clinical product manufacturing facility in Shelton, CT. It has been completed this month. This is only the beginning. As our clinical product pipeline matures in a couple of years, we anticipate building a world class pharma company with thousands of skilled employees and manufacturing sites with a much larger scale capacity. NanoViricides' product line targets over $60Bn of worldwide markets in antiviral drugs including biopharmaceuticals against FLU, HIV, Dengue, MERS, and more that are based on our globally patented nanomedicines technology. This facility will provide clinical quantities of cGMP products for all our nanoviricides(r) drug candidates. In addition, this facility will be available for contract manufacturing cGMP production of drug candidates for other Start-up Pharma companies as well. Since such manufacturing is a critical hurdle for building any pharma startup into clinical stage company, we believe it fills a critical industry need. My recent participation at a Yale conference suggests that some of their projects may benefit from our manufacturing capabilities. UConn likely also has similar projects. In addition, we have received inquiries from other startup pharma companies as well. This facility is thus poised to help foster a pharma start-up hub in Connecticut.
You may recall that NanoViricides, Inc. was awarded the International Alternative Investments Review (IAIR) group's Award 2014 for Leadership in the Nanomedicines Sector in North America. The award ceremony took place at the Yale Club on April 15th, 2014. The awards are nominated by their global readership, and vetted by their editorial Committee. This a very important international recognition for us. In addition, BusinessNewHaven Group recently named me Researcher of the Year 2014.
We are planning the Grand Opening ceremony of our biotech manufacturing facility in Shelton, CT on Monday, July 21 2014 from Noon to 3pm. We would be delighted if you could attend the opening ceremony for this world-class cGMP facility. Congressman Jim Himes will be the guest of honor, and Senator Chris Murphy is sending a delegate. Also, State Representative Jason Perillo and the Mayor of Shelton, Mr. Mark Lauretti have accepted our invitation. We have also invited Senator Richard Blumenthal, CT Governor Dannell P. Malloy, CT Lt. Governor Nancy Wyman, and State Representative Kevin Kelley. A number of high net worth individuals that have been avid supporters and investors of NanoViricides, Inc. are anticipated to be attending as well as our collaborators, bankers, and others. The event will run from 12noon to 3pm. Light lunch will be served.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM